Skip to main content
TIANYU BIO-TECHNOLOGY CO.,LTD. logo

TIANYU BIO-TECHNOLOGY CO.,LTD. — Investor Relations & Filings

Ticker · 603717 ISIN · CNE1000030W1 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,622 across all filing types
Latest filing 2023-06-27 Annual Report
Country CN China
Listing Shanghai Stock Exchange 603717

About TIANYU BIO-TECHNOLOGY CO.,LTD.

https://www.tianyubiotech.com/

TIANYU BIO-TECHNOLOGY CO.,LTD. specializes in the research, development, and large-scale production of active pharmaceutical ingredients (APIs) and advanced pharmaceutical intermediates. The company focuses on therapeutic areas such as cardiovascular health, diabetes management, and anti-viral treatments. Its core product portfolio includes various sartan-based intermediates and other complex organic synthesis products. TIANYU BIO-TECHNOLOGY emphasizes rigorous quality management systems and adheres to international regulatory standards to ensure product safety and efficacy. By leveraging advanced chemical synthesis technologies and a robust R&D infrastructure, the company provides customized manufacturing solutions and high-quality chemical components to global pharmaceutical partners. Its operations are characterized by a commitment to technical innovation and process optimization in the synthesis of complex molecules.

Recent filings

Filing Released Lang Actions
关于回复上海证券交易所监管工作函的公告
Annual Report Classification · 95% confidence The document is a detailed response to a regulatory inquiry from the Shanghai Stock Exchange regarding the company's 2022 annual report. It contains extensive financial data, operational details, and auditor opinions related to the company's 2022 fiscal year performance, including revenue, profit, business segments, and asset details. The presence of comprehensive financial figures, business analysis, and auditor commentary indicates this is part of the Annual Report or closely related to it. The document is lengthy (15,000 characters) and contains substantive financial data and analysis, not merely an announcement or certification. Therefore, it fits the definition of an Annual Report (10-K). FY 2022
2023-06-27 Chinese
关于2022年股票期权激励计划首次授予股票期权第一个行权期限制行权期间的提示性公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (703 characters) regarding the restriction period for exercising stock options under the company's 2022 stock option incentive plan. It includes specific dates for the restriction period and mentions compliance with regulatory requirements. There is no financial data, no detailed report, and it is not a full report or presentation. The document is an announcement related to stock option exercise restrictions, which fits best under Regulatory Filings (RNS) as it does not match other more specific categories like Capital/Financing Update or Director's Dealing. The document is not a report itself but an announcement of a regulatory compliance matter.
2023-06-27 Chinese
关于2022年年度报告补充披露公告
Report Publication Announcement Classification · 95% confidence The document is titled as a supplementary disclosure announcement related to the 2022 Annual Report of Tianyu Ecological Environment Co., Ltd. It references the original 2022 Annual Report published on April 29, 2023, and provides additional disclosures regarding regulatory penalties involving the controlling shareholder. The document states that the revised 2022 Annual Report (amended version) is published on the exchange website on the same day. The document length is short (1133 characters) and primarily serves to announce supplementary disclosures to the previously published annual report rather than presenting the full annual report itself. According to the 'Menu vs Meal' rule, such a document is an announcement about the report, not the report itself. Therefore, the appropriate classification is Report Publication Announcement (RPA).
2023-06-27 Chinese
关于2022年股票期权激励计划首次授予股票期权第一个行权期自主行权实施公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the implementation of the first exercise period of a 2022 stock option incentive plan by the company Tianyu Ecology Environment Co., Ltd. It details the number of stock options exercised, the approval and disclosure process, the conditions for exercising the options, and the legal and supervisory opinions. The document is focused on the stock option plan exercise event and related corporate governance and compliance matters. It is not a full financial report, earnings release, or management discussion, but rather a specific corporate announcement about stock option exercise and related approvals. This fits best under the category of Capital/Financing Update (CAP), as it relates to changes in capital structure through stock option exercises and issuance of shares to incentive plan participants.
2023-05-29 Chinese
关于向特定对象发行股票申请获得中国证券监督管理委员会同意注册批复的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from Tianyu Ecological Environment Co., Ltd. regarding the approval from the China Securities Regulatory Commission (CSRC) for a specific private placement of shares. It mentions the registration approval for issuing shares to specific investors and outlines the conditions and validity period of the approval. The content focuses on capital raising activities and regulatory approval for share issuance. The document length is short (579 characters), and it is not a full report but an announcement of a capital/financing update. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2023-05-25 Chinese
关于2022年度业绩说明会召开情况的公告
Investor Presentation Classification · 95% confidence The document is titled as an announcement regarding the holding of the 2022 annual performance briefing meeting (业绩说明会). It details the date, participants, and the main questions raised by investors along with the company's responses. The content focuses on explaining the company's recent financial performance, business outlook, and strategic plans in a Q&A format. There are no full financial statements or comprehensive financial data presented, only management commentary and investor interaction summary. The document length is relatively short (2109 characters), and it is clearly an announcement about the holding and content of a performance briefing rather than the full annual report or earnings release. This matches the definition of an Investor Presentation (IP) or possibly a Management Discussion and Analysis (MDA). However, since it is specifically about the performance briefing meeting and includes Q&A with investors, it aligns best with an Investor Presentation (IP).
2023-05-23 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.